Peijia Medical Ltd
Company Profile
Business description
Peijia Medical Ltdis a provider of inventive medical products and solutions. It focuses on the high-growth interventional procedural medical device market in China. Its products and product candidates target large, fast-growing and under-penetrated markets with high entry barriers, including the transcatheter valve therapeutic medical device market and the neurointerventional procedural medical device market. The Company's product pipeline consists of transcatheter valve therapeutic and neurointerventional products and product candidates spanning three key business segments: Transcatheter Valve Therapeutic Business, Future Technology Business and Neurointerventional Business.
Contact
No.18 Yangjiatian Road
Suzhou Industrial Park
Jiangsu Province
Suzhou
CHNT: +86 51281877166
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
1,022
Stocks News & Analysis
stocks
Chart of the Week: CGT reform strengthens the case for dividend investing
stocks
Finding ASX opportunities in lofty market conditions
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,136.30 | 49.20 | -0.54% |
| CAC 40 | 8,408.27 | 50.51 | -0.60% |
| DAX 40 | 25,460.48 | 3.53 | -0.01% |
| Dow JONES (US) | 51,594.14 | 1,153.18 | -2.19% |
| FTSE 100 | 10,908.41 | 37.39 | 0.34% |
| HKSE | 25,807.92 | 497.07 | 1.96% |
| NASDAQ | 24,442.94 | 433.97 | -1.74% |
| Nikkei 225 | 62,329.08 | 894.89 | 1.46% |
| NZX 50 Index | 13,786.62 | 190.05 | -1.36% |
| S&P 500 | 7,316.15 | 112.63 | -1.52% |
| S&P/ASX 200 | 8,981.20 | 43.60 | -0.48% |
| SSE Composite Index | 3,827.59 | 0.88 | -0.02% |